SYLVESTER NWOSU: Open Payments
NPI 1073856944 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,052 in 12 payments from 5 companies in 2025. Trend: 2023 $1,182 · 2024 $472 · 2025 $1,052
Food & beverage: $1,052
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $324 |
| Neurocrine BioSciences, Inc. | 3 | $233 |
| Teva Pharmaceuticals USA, Inc. | 2 | $227 |
| E.R. Squibb & Sons, L.L.C. | 2 | $144 |
| Janssen Pharmaceuticals, Inc | 2 | $124 |
Products named: UZEDY, LYBALVI, INGREZZA, COBENFY, ARISTADA, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
